Home
HEALTH CARE
Allergy and hay fever
Antineoplastic and immunomodulating agents
Circulatory system
Colds and flu
Dermatology
Digestive system
Eyes
For diabetics
Homeopathy
Musculoskeletal system
Non-sex hormones
Nutrikosmetics
Pain
Preparations for the treatment of infections
Sex and contraception
The immune system
The nervous system
Urogenital tract
Vitamins and minerals
HEALTHY LIFESTYLE
For athletes
Healthy food
Slimming
HYGIENE
Disinfection
Ear hygiene
Hot and cold compresses
Intimate hygiene
Laundry products
Oral hygiene
Slices and sticks
Urinary incontinence
COSMETICS
Cosmetic articles
For eyelashes and eyebrows
For face
For hair
For hands and nails
For the body
Soap
Sunbathing
To the feet
To the mouth
FOR HIM
Cosmetics for men
Health
PREGNANCY AND MOTHERHOOD
Accessories
Cosmetics for pregnant women
Health in pregnancy
Supporting fertility
CHILD
Baby nutrition
Child health
Cosmetics for children
Hygiene items for children
Oral hygiene (for children)
Scrolling
HEALTH CARE
Ketilept Retard 50mg 60 long-acting tablets — Made in Hungary — Free Delivery
Ketilept Retard 50mg 60 long-acting tablets — Made in Hungary — Free Delivery
Brand:
EGIS
Product Code:
Ketilept Retard 50mg
Availability:
In Stock
$28.81
Add to Cart
Description
Product description
Ketilept® Retard tablets are indicated for the treatment of:
Schizophrenia, including prevention of relapse in patients with stable schizophrenia who received maintenance therapy with quetiapine;
Bipolar disorder, in particular:
for the treatment of moderate and severe manic episodes in bipolar disorder;
for the treatment of severe depressive episodes in bipolar disorder;
for the prevention of relapse of the disease in patients with bipolar disorder, in patients with manic or depressive episodes, in which quetiapine is effective.
As adjunctive therapy for major depressive episodes in patients with major depressive disorder (SID) who have a suboptimal response to antidepressant monotherapy. Before starting therapy, the doctor should carefully study the safety profile of Ketilept® retard.
Compound
Active ingredient: quetiapine;
1 long-acting film-coated tablet contains 57.56 mg, 172.680 mg, 230.24 mg, 345.36 mg 460.48 mg quetiapine fumarate (corresponding to 50 mg, 150 mg, 200 mg, 300 mg or 400 mg quetiapine );
Excipients: methacrylate copolymer (type A), lactose (spray dried SD 250), crystalline maltose (Advantose 100), talc, magnesium stearate, vegetable;
Shell composition: methacrylate copolymer (type A), triethyl citrate (Citrofol).
Contraindications
hypersensitivity to the components of the preparation;
concomitant use of inhibitors of cytochrome P450 3A4, such as inhibitors of HIV protease, azole-containing antifungals, erythromycin, clarithromycin and nefazodone.
Mode of application
There are different dosing regimens for each indication. It should be ensured that the patient is prescribed a dosage that is appropriate for their condition. The dose of the preparation and the duration of the course of treatment is determined by the doctor individually for each patient, depending on the indications and severity of the disease. For oral use. The preparation can be taken regardless of the meal. Tablets should be swallowed whole, without breaking, chewing or crushing them.
Application features
pregnant
During pregnancy, the preparation can be prescribed only if the expected benefit outweighs the potential risk.
Children
The preparation is not recommended for use in children due to the lack of data supporting its use in this age group.
Drivers
Patients are not recommended to drive a car or other mechanisms until individual sensitivity to such effects is determined.
Overdose
In general, the symptoms reported were due to an increase in the known pharmacological effects of the preparation, such as drowsiness and sedation, tachycardia and hypotension. There is no specific antidote for quetiapine. In severe cases, consideration should be given to the use of multidirectional measures and intensive care, including the restoration and maintenance of airway patency, provision of adequate oxygenation and ventilation of the lungs, monitoring and support of the cardiovascular system. Published reports describe cases of elimination of serious central nervous system (CNS) reactions, including coma and delirium, with intravenous administration of physostigmine (1-2 mg) under continuous ECG monitoring.
Side effects
When taking quetiapine, the following adverse reactions were most often reported: drowsiness, dizziness, dry mouth, headache, withdrawal symptoms (in case of discontinuation of the preparation), increase in serum triglycerides, increase in total cholesterol (especially LDL cholesterol), decrease in blood HDL cholesterol, weight gain, decreased hemoglobin and extrapyramidal symptoms.
Interaction
The preparation should be used with caution in patients receiving other preparations with anticholinergic (muscarinic) effects.
Despite the fact that quetiapine primarily acts on the central nervous system (CNS), Quetixol should be used with caution in combination with other preparations that have a similar effect, and with alcohol.
Concomitant use of cytochrome P450 3A4 inhibitors such as HIV protease inhibitors, azole antifungals, erythromycin, clarithromycin and nefazodone.
Storage conditions
Store below 30°C.
Keep out of the reach of children.
Shelf life - 3 years.
0 reviews
There are no reviews for this product.